Evidence map›Paper›PMID 32601330›Full record

ArticleScientific reports2020

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET.

F C Trudzinski, R A Jörres, P Alter, K Kahnert, B Waschki, C Herr, C Kellerer, A Omlor, C F Vogelmeier, S Fähndrich and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01245933 (Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis and Utilisation of Health Care Resources in Patients With COPD), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01245933 completednot on this map

Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis and Utilisation of Health Care Resources in Patients With COPD

TypeobservationalSponsorPhilipps University MarburgRan2010 to 2023Enrolled2,741ConditionsChronic Obstructive Pulmonary Disease (COPD)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. The Diagnosis and Treatment of COPD and Its Comorbidities.Deutsches Arzteblatt international · 2023
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 20 institutions in 2 countries.

F C TrudzinskiDepartment of Internal Medicine V - Pulmonology, Allergology, Critical Care Care Medicine, Saarland University Hospital, Homburg, Germany. franziska.trudzinski@med.uni-heidelberg.de.
R A JörresInstitute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig Maximilians University (LMU), Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.
P AlterDepartment of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Member of the German Center for Lung Research (DZL), Marburg, Germany.
K KahnertDepartment of Internal Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Munich, Germany.
B WaschkiDepartment of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
C HerrDepartment of Internal Medicine V - Pulmonology, Allergology, Critical Care Care Medicine, Saarland University Hospital, Homburg, Germany.
C KellererTUM School of Medicine, Institute of General Practice and Health Services Research, Technical University of Munich, Orleansstraße 47, 81667, Munich, Germany.
A OmlorDepartment of Internal Medicine V - Pulmonology, Allergology, Critical Care Care Medicine, Saarland University Hospital, Homburg, Germany.
C F VogelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Member of the German Center for Lung Research (DZL), Marburg, Germany.
S FähndrichDepartment of Pneumology, University Hospital Freiburg, Freiburg, Germany.
H WatzPulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
T WelteClinic for Pneumology, Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Hannover, Germany.
B JanyDepartment of Internal Medicine, Medical Mission Hospital, Academic Teaching Hospital, Julius Maximilian University of Würzburg, Würzburg, Germany.
S SöhlerDepartment of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Member of the German Center for Lung Research (DZL), Marburg, Germany.
F BiertzInstitute for Biostatistics, Hannover Medical School, Hannover, Germany.
F HerthDepartment of Pneumology and Critical Care Medicine, Thoraxklinik University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
H-U KauczorDepartment of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Translational Lung Research Center Heidelberg (TLRC-H) member of the German Center of Lung Research, Heidelberg, Germany.
R BalsDepartment of Internal Medicine V - Pulmonology, Allergology, Critical Care Care Medicine, Saarland University Hospital, Homburg, Germany.
COSYCONET consortium
German Center for Lung Research · DESaarland University · DELudwig-Maximilians-Universität München · DEBG University Hospital Bergmannsheil Bochum · DEHeidelberg University · DEMedizinische Hochschule Hannover · DEResearch Center Borstel - Leibniz Lung Center · DERuhrlandklinik · DEUniversitätsmedizin Greifswald · DEAsklepios Fachkliniken München-Gauting · DEEvangelische Lungenklinik Berlin · DEHamburg Institute for Therapy Research · DEJustus-Liebig-Universität Gießen · DEKlinik Bad Reichenhall · DEKlinik Donaustauf · DEKrankenhaus Bethanien · DELöwenstein Medical (Germany) · DELungenClinic Grosshansdorf · DEMedical Mission Institute · DEParacelsus Medizinische Privatuniversität · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied whether in patients with stable COPD blood gases (BG), especially oxygenated hemoglobin (OxyHem) as a novel biomarker confer information on disease burden and prognosis and how this adds to the information provided by the comorbidity pattern and systemic inflammation. Data from 2137 patients (GOLD grades 1-4) of the baseline dataset of the COSYCONET COPD cohort were used. The associations with dyspnea, exacerbation history, BODE-Index (cut-off ≤2) and all-cause mortality over 3 years of follow-up were determined by logistic and Cox regression analyses, with sex, age, BMI and pack years as covariates. Predictive values were evaluated by ROC curves. Capillary blood gases included SaO

Indexed as

AdultAgedAged, 80 and overBiomarkersBlood Gas AnalysisFemaleHumansInflammationMaleMiddle AgedOxyhemoglobinsPrognosisPulmonary Disease, Chronic ObstructiveSeverity of Illness IndexSurvival RateBiomarkersOxyhemoglobins

Identifiers

PMID32601330
PMCPMC7324620
OpenAlexW3040029017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.